US equities
|
NVDA
$176.45
▼-5.46%
AMD
$504.32
▲+12.31%
MU
$728.67
▲+5.61%
SPCX
$141.06
▲+5.06%
SNDK
$884.05
▲+5.87%
AMZN
$267.90
▲+3.32%
TSLA
$376.46
▲+5.09%
META
$642.30
▲+5.27%
NVDA
$176.45
▼-5.46%
AMD
$504.32
▲+12.31%
MU
$728.67
▲+5.61%
SPCX
$141.06
▲+5.06%
SNDK
$884.05
▲+5.87%
AMZN
$267.90
▲+3.32%
TSLA
$376.46
▲+5.09%
META
$642.30
▲+5.27%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Givaudan Sa ADR
(OP:
GVDNY
)
99.00
+0.50 (+0.51%)
Delayed Quote
Updated: 1:05 PM EST, Nov 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Givaudan Sa ADR
How AGI Could Stir Up the Beverage Industry
↗
October 26, 2026
Artificial general intelligence could give beverage companies the power to rethink everything from factory operations to flavor development.
Via
The Motley Fool
Topics
Artificial Intelligence
Supply Chain
Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
↗
September 27, 2023
Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs
Via
InvestorPlace
3 New ETFs Worth a Spot on Your 2022 Buy List
↗
December 28, 2021
New ETFs are small funds without considerable track records. But but these three exchange-traded funds deserve a further look for 2022.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 2, 2021
↗
July 02, 2021
Upgrades According to Deutsche Bank, the prior rating for Encompass Health Corp (NYSE:
Via
Benzinga